• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

    11.56 +0.62 (+5.67%)
    Streaming Delayed Price Updated: 3:28 PM EDT, Sep 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,890,223
    Open 10.80
    Bid (Size) 11.54 (500)
    Ask (Size) 11.56 (1,400)
    Prev. Close 10.94
    Today's Range 10.80 - 11.74
    52wk Range 4.750 - 11.64
    Shares Outstanding 133,976,538
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology (VIR) Q2 2026 Earnings Call Transcript ↗
    HDV combination therapy achieved 88% viral clearance, advancing toward Phase 3 readouts. 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +94.6%
    +94.6%
    1 Month
    +29.9%
    +29.9%
    3 Month
    +28.0%
    +28.0%
    6 Month
    +23.8%
    +23.8%
    1 Year
    +131.2%
    +131.2%

    More News

    Read More
    News headline image
    Vir Biotechnology Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Vir Biotechnology (NASDAQ:VIR) Jumps 10% on Q2 Beat and Astellas Collaboration ↗
    Via Chartmill
    7 Bull Flag Setups Found With the ChartMill Stock Screener ↗
    Via Chartmill
    VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick ↗
    Via Chartmill
    News headline image
    Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology Announces Chief Financial Officer Transition
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally ↗
    Via The Motley Fool
    News headline image
    Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Energy Vault Stock Has Surged 500%. One Major Holder Just Sold 3 Million Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗
    Via The Motley Fool
    News headline image
    "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    Vir Biotechnology's Chairman of the Board Sold 22,000 Company Shares. Here's What That Means for Investors. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Vir (VIR) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
    From Vir Biotechnology
    Via Business Wire
    News headline image
    Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
    From Vir Biotechnology, Inc.
    Via Business Wire
    News headline image
    Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Unusual volume stocks are being observed in Monday's session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Vir Biotechnology, Inc. - Common Stock publicly traded?
    Yes, Vir Biotechnology, Inc. - Common Stock is publicly traded.
    What exchange does Vir Biotechnology, Inc. - Common Stock trade on?
    Vir Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vir Biotechnology, Inc. - Common Stock?
    The ticker symbol for Vir Biotechnology, Inc. - Common Stock is VIR on the Nasdaq Stock Market
    What is the current price of Vir Biotechnology, Inc. - Common Stock?
    The current price of Vir Biotechnology, Inc. - Common Stock is 11.56
    When was Vir Biotechnology, Inc. - Common Stock last traded?
    The last trade of Vir Biotechnology, Inc. - Common Stock was at 09/01/26 03:28 PM ET
    What is the market capitalization of Vir Biotechnology, Inc. - Common Stock?
    The market capitalization of Vir Biotechnology, Inc. - Common Stock is 1.55B
    How many shares of Vir Biotechnology, Inc. - Common Stock are outstanding?
    Vir Biotechnology, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.